Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec

CMAJ. Canadian Medical Association Journal

Volumn 173, Issue 9, 2005, Pages 1037-1041

  Pépin, Jacques ^a,b   Valiquette, Louis ^a   Cossette, Benoit ^b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; CANADA; CLOSTRIDIUM DIFFICILE; COMORBIDITY; COMPARATIVE ANATOMY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; EPIDEMIC; FEMALE; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; TIME SERIES ANALYSIS;

EID: 27544511378     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.050978     Document Type: Article

References (26)

1. Alfa M, Du T, Beda G. Survey of incidence of Clostridium difficile infection in Canadian hospitals and diagnostic approaches. J Clin Microbiol 1998;36:2076-80.
2. Eggertson L. C. difficile: by the numbers. CMAJ 2004;171(11):1331-2.
3. Valiquette L, Low DE, Pépin J, McGeer A. Clostridium difficile infection in hospitals: a brewing storm. CMAJ 2004;171(1):27-9.
4. Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171(5):466-72.
5. Gaulin C, Hubert B, Allard R. Évolution des infections à C. difficile dans les centres hospitallers québécois 1999-2003 à partir du fichier Med-Echo [abstract]. Special symposium on C. difficile, Association des Médecins Microbiologistes-Infectiologues du Québec, Montréal, September 2004.
6. Institut National de Santé Publique. La surveillance des diarrhées associées aux infections à Clostridium difficile. Deuxième rapport tiré du système de surveillance des infections à Clostridium difficile (SSICD) de l'Institut National de Santé Publique du Québec. Available: www.inspq.qc.ca/pdf/ publications/370-Resultats CDifficile-22Aout2004-05Fevrier2005.pdf (accessed 2005 Sept 6).
7. Direction risques biologiques, environnementaux et occupationnels et Laboratoire de santé publique du Québec. Surveillance des diarrhées associées à Clostridium difficile au Québec: Bilan du 22 août au 31 mars 2005. Sainte-Foy (QC): Institut national de santé publique du Québec; 2005. Available: www.inspq.qc.ca/pdf/publications /389-SurveillanceCDifficile_Bilan22aouto4- 31mars05.pdf (accessed 2005 Sept 20).
8. Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ 2004;171(1):33-8.
9. Warny M, Pépin J, Fang A, Killgore G, Thompson A, Brazier J, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005;366:1079-84.
10. Hospitalisations pour des soins de courte durée dans les installations de soins généraux et spécialisés participant au système Med-Écho selon le groupe d'âge de l'usager, au Québec, 1992-1993 et 2003-04. Québec (QC): Ministère de la Santé et des Services sociaux du Québec; 2005. Available: www.msss.gouv.qc.ca/statistiques /produc_util.html (accessed 2005 Sept 20).
11. Pépin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005;40:1591-7.
12. Pépin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005 Sept 20 [Epub ahead of print]. Available: www.journals.uchicago.edu/CID /journal/rapid.html (accessed 2005 Sept 21).
13. Health Protection Agency. Voluntary reporting of Clostridium difficile, England, Wales and Northern Ireland: 2004. Commun Dis Rep CDR Wkly 2005;15:1-3. Available: www.hpa.org.uk/cdr/archives/2005/cdr2005.pdf (accessed 2005 Sept 20).
14. Health Protection Agency. Outbreak of Clostridium difficile infection in a hospital in south east England. Commun Dis Rep CDR Wkly 2005;15:2-3. Available: www.hpa.org.uk/cdr/archives/2005/cdr2405.pdf (accessed 2005 Sept 6).
15. McDonald LC, Killgore GE, Thompson A, Johnson S, Gerding DN; C. difficile Investigation Team. Emergence of an epidemic strain of Clostridium difficile in the United States 2001-4: potential role for virulence factors and antimicrobial resistance traits [abstract LB-2]. 42nd annual meeting of the Infectious Diseases Society of America, Boston, October 2004.
16. Van Steenbergen I, Debast S, van Kregten E, van den Berg R, Notermans D, Kuijper E. Isolation of Clostridium difficile ribotype 027, toxinotype III in the Netherlands after increase in C. difficile associated diarrhoea. Eurosurveillance Wkly 2005;10. Available: www.eurosurveillance.org/ew/2005/ 050714.asp (accessed 2005 Sept 20).
17. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002;34:346-53.
18. Department of Health. Results of the first year of mandatory Clostridium difficile reporting: January to December 2004. Commun Dis Rep CDR Wkly 2005;15(34):1-3. Available: www.dh.gov.uk/assetRoot/04/11/84/79/04118479.pdf (accessed 2005 Sept 20).
19. ProMED-mail. Clostridium difficile, increased virulence - UK (England) (05). ProMED-mail 2005 June 30: 20050630.1843. Available: www.promedmail.org Accessed 6 September 2005.
20. Riley TV, Codde JP, Rouse IL. Increased length of hospital stay due to Clostridium difficile associated diarrhoea. Lancet 1995;345:455-6.
21. Wilcox MH, Cunniffe JG, Trundle C, Redpath C. Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 1996;34:23-30.
22. Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, et al. Fulminant Closttidium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002;235:363-72.
23. Muto CA, Pokrywka M, Shutt K, Mendelsohn AB, Nouri K, Posey K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. In feet Control Hosp Epidemiol 2005;26:273-80.
24. IMS Health. Canadian CompuScript, Anti-infective Class 2003-2004. Montreal, Canada.
25. Patrick DM, Marra F, Hutchinson J, Monnet DL, Ng H, Bowie WR. Per capita antibiotic consumption: how does a North American jurisdiction compare with Europe? Clin Infect Dis 2004;39:11-7.
26. Goossens H, Ferech M, Vander Stichele R. Elseviers M for the ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579-87.